Morgan Stanley Payments to acquire available-for-sale debt securities decreased by 22.5% to $7.81B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 2.6%, from $7.61B to $7.81B. Over 4 years (FY 2021 to FY 2025), Payments to acquire available-for-sale debt securities shows a downward trend with a -3.7% CAGR.
An increase indicates the company is actively managing its cash reserves by investing in liquid assets, while a decrease may suggest a shift toward other uses of capital.
This metric tracks the cash outflow used to purchase available-for-sale debt securities as part of the company's treasur...
Standard treasury management metric; common for cash-rich biotech firms managing large balance sheets.
is_jpm_payments_to_acquire_afs_securities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.62B | $10.62B | $10.62B | $14.13B | $4.50B | $4.01B | $1.97B | $3.48B | $2.94B | $3.11B | $13.56B | $9.02B | $9.35B | $9.35B | $7.61B | $6.56B | $12.13B | $10.08B | $7.81B |
| QoQ Change | — | +0.0% | +0.0% | +33.0% | -68.2% | -10.8% | -51.0% | +76.8% | -15.5% | +5.8% | +336.0% | -33.5% | +3.7% | +0.0% | -18.6% | -13.8% | +84.8% | -16.9% | -22.5% |
| YoY Change | — | — | — | — | -57.6% | -62.2% | -81.5% | -75.4% | -34.7% | -22.5% | +589.5% | +159.5% | +218.2% | +200.7% | -43.9% | -27.2% | +29.7% | +7.8% | +2.6% |
We use cookies for analytics. See our Privacy and Cookie Policy.